New Science—Better Testing Technology
We use unique, cutting-edge and patent-protected PCR technology for the molecular diagnostics market, which allows for more affordable testing.
Our qPCR tests are ideal for CLIA-certified labs that value ease of use, affordability, and adaptability.
Request quote for COVD-19 PCR test kits
Compassionately Priced COVID-19 Test Kits
Made Possible by CoPrimers™
Co-Diagnostics offers a range of products and services to suit the needs of diagnostics laboratories, research institutions, and enterprises across the globe that rely on PCR technology. Learn about our patented CoPrimers™, which are a leading-edge, patented platform technology developed by Co-Diagnostics that dramatically enhances the output of molecular diagnostic tests conducted via real-time polymerase chain reaction (“PCR”) tests.
Affordable and Compassionately Priced
COVID-19 test kits as low as $10 USD per kit.
Trusted
FDA authorized and trusted by state government programs, nationwide labs, professional athletic organizations, school districts, and universities across the globe.
Open Source—Works with Most qPCR Machines
ThermoFisher ABI 7500 & QuantStudio, Bio-Rad CFX96, etc*
High Throughput and Speed
Highly-specific, single-well PCR test, allowing higher throughput compared to tests that require multiple wells.
Reliable and Accurate
Consistently demonstrates remarkable sensitivity and specificity across independent evaluations.
Understanding CoPrimers™
The unique, proprietary structure of
The CoPrimer™ Binding Process
NO PRIMER DIMERS, NO OPTIMIZATION, REAL MULTIPLEXING
1.
Long PROBE quickly “anchors” bringing the short PRIMER into close proximity with the DNA target
2.
The DNA strands fold, allowing the CoDX™ short primer to bind
3.
When the polymerase extends, the capture (probe) is cleaved, releasing the fluorophore
One of the most important attributes of Co-Diagnostics’ CoPrimer technology is the virtual elimination of “primer-dimers,” the principal source of false positives in diagnostic testing. Primer-dimers are essentially the amplification of errors that can take place during the course of a molecular diagnostic test. These errors dramatically minimize the accuracy of the test and lead to false results and/or inaccurate diagnoses.
The importance of test accuracy cannot be overstated, particularly in a medical diagnostic situation.
The End Result of CoPrimer™ Cooperativity
A Revolutionary Improvement in the
Top Three Objectives of Molecular Diagnostics
1.
Increased
Specificity
2.
Sharper
Sensitivity
3.
Mega
Multiplexing
Creating 80% reduction in research, design and development costs
DISRUPTIVELY AFFORDABLE
The worldwide low-cost leader of
molecular diagnostics services.
Logix Smart™ COVID-19 Kit Specs
The Logix Smart™ Coronavirus Disease 2019 (COVID-19) Test kit is an in vitro diagnostic test that uses our patented CoPrimer™ technology for the qualitative detection of the RNA from SARS-CoV-2 coronavirus (COVID-19).
The test operates using a single step real-time reverse transcriptase-polymerase chain reaction (RT-PCR) process in lower respiratory tract fluids (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract fluids (e.g. nasopharyngeal and oropharyngeal swabs) from patients who meet the clinical criteria (e.g. signs and symptoms) for coronavirus disease 2019 (COVID-19) as established by WHO (WHO, 2020) and the US CDC (CDC, 2020) (e.g. fever, cough, shortness of breath, travel history to China).
Ready-to-use Master Mix, complete with RNaseP internal positive control to verify sample quality
Positive Control (PC), to verify the performance of the master mix
Nuclease-Free Water as a negative control, to verify master mix is free from contamination
NOTE** THE TEST KIT IS ONLY SUITABLE FOR LABS CERTIFIED TO PERFORM HIGH COMPLEXITY TESTS)
Please send me more information about research solutions
Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.
Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States
1 (801) 438-1036
© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.
COMPANY
LATEST NEWS RELEASE
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share
Salt Lake City, Utah – November 2, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that following the discovery of an incorrectly...
ARCHIVE
Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.
Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States
1 (801) 438-1036
COMPANY
© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.